MS3-2 TREATMENT STRATEGY BASED ON THE RESULTS OF GENE PANELS

por Takeda, Masayuki
Publicado en Neurooncol Adv (2019)

Implications of the success of EGFR-targeted therapy in advanced non–small cell lung cancer for its application to the adjuvant setting

por Takeda, Masayuki
Publicado en J Thorac Dis (2020)

Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors in patients with epidermal growth factor receptor gene mutation-positive lung cancer

por Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado en Mol Clin Oncol (2017)

First- and Second-Generation EGFR-TKIs Are All Replaced to Osimertinib in Chemo-Naive EGFR Mutation-Positive Non-Small Cell Lung Cancer?

por Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado en Int J Mol Sci (2019)

Percutaneous transthoracic needle biopsy of the lung in the era of precision medicine

por Sakai, Hitomi, Takeda, Masayuki
Publicado en J Thorac Dis (2019)

Survival Outcome Assessed According to Tumor Response and Shrinkage Pattern in Patients with EGFR Mutation–Positive Non–Small-Cell Lung Cancer Treated with Gefitinib or Erlotinib...

por Takeda, Masayuki, Okamoto, Isamu, Nakagawa, Kazuhiko
Publicado 2014

Clinical development of nintedanib for advanced non-small-cell lung cancer

por Takeda, Masayuki, Okamoto, Isamu, Nakagawa, Kazuhiko
Publicado en Ther Clin Risk Manag (2015)

A first attempt to establish a definition of oligometastatic non-small cell lung cancer by a European consensus group

por Haratani, Koji, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado en J Thorac Dis (2019)

Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?

por Kanemura, Hiroaki, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado en Transl Lung Cancer Res (2020)

Effect of genotyped bulls with different numbers of phenotyped progenies on quantitative trait loci detection and genomic evaluation in a simulated cattle population

por Takeda, Masayuki, Uemoto, Yoshinobu, Satoh, Masahiro
Publicado en Anim Sci J (2020)

A case of severe cerebral embolism after chemotherapy for HER2-positive gastric cancer

por Takahama, Takayuki, Takeda, Masayuki, Nishina, Shinichi, Nakagawa, Kazuhiko
Publicado en BMC Res Notes (2015)

Tuberculous Granuloma in the Scrotal Skin After Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer: A Case Report

por Shimura, Hiroshi, Ihara, Tatsuya, Mitsui, Takahiko, Takeda, Masayuki
Publicado en Urol Case Rep (2017)

Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer

por Takeda, Masayuki, Okamoto, Isamu, Nishimura, Yasumasa, Nakagawa, Kazuhiko
Publicado en Lung Cancer (Auckl) (2011)

Successful long-term treatment of non–small cell lung cancer positive for RET rearrangement with pemetrexed

por Takeda, Masayuki, Sakai, Kazuko, Nishio, Kazuto, Nakagawa, Kazuhiko
Publicado en Onco Targets Ther (2019)

Blockade of Acid-Sensing Ion Channels Increases Urinary Bladder Capacity With or Without Intravesical Irritation in Mice

por Yoshiyama, Mitsuharu, Kobayashi, Hideki, Takeda, Masayuki, Araki, Isao
Publicado en Front Physiol (2020)

Corrigendum: Blockade of Acid-Sensing Ion Channels Increases Urinary Bladder Capacity With or Without Intravesical Irritation in Mice

por Yoshiyama, Mitsuharu, Kobayashi, Hideki, Takeda, Masayuki, Araki, Isao
Publicado en Front Physiol (2020)

Interstitial lung disease associated with capmatinib therapy in a patient with non‐small cell lung cancer harboring a skipping mutation of MET exon 14

por Kanemura, Hiroaki, Takeda, Masayuki, Shimizu, Shigeki, Nakagawa, Kazuhiko
Publicado en Thorac Cancer (2020)

Discovery science 10th international conference, DS 2007, Sendai, Japan, October 1-4, 2007 ; proceedings /

por DS 2007, Corruble, Vincent., Takeda, Masayuki., Suzuki, Einoshin.
Publicado 2007.

Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevaciz...

por Takeda Masayuki, Okamoto Isamu, Yamanaka Takeharu, Nakagawa Kazuhiko, Nakanishi Yoichi
Publicado 2012-08-01

Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevaciz...

por Takeda, Masayuki, Okamoto, Isamu, Yamanaka, Takeharu, Nakagawa, Kazuhiko, Nakanishi, Yoichi
Publicado 2012